NEW YORK (AP) When children can get COVID-19 vaccines will depend on their age, but some teenagers could be rolling up their sleeves before long.
The Pfizer vaccine already is cleared for use starting at age 16. That means some high schoolers could get their shots whenever they become eligible in their area, either because of a medical condition or once availability opens up.
Pfizer and Moderna expect to release study data on children ages 12 and older over the summer. The companies also plan to start studies in children 11 and younger later this year. Moderna's vaccine is currently cleared for use for people 18 and older.
President Biden keeps a note card in his suit pocket with the running tally of how many Americans have died from COVID-19 and how many have been vaccinated. Evan Vucci/AP hide caption
President Biden keeps a note card in his suit pocket with the running tally of how many Americans have died from COVID-19 and how many have been vaccinated.
President Biden said on Tuesday that a key milestone in the fight against COVID-19 could be reached two months faster than earlier projected. By the end of May, there should be enough vaccine doses for every adult in America, he said a dramatic improvement to his initial timetable for late July.
A turning point in speeding up that pledge came a few weeks ago, on a Sunday afternoon in early February, during a phone call with Johnson & Johnson executives that had been planned for 15 minutes but stretched for longer than an hour, two senior administration officials told NPR.
Biden administration officials had been pushing vaccine-makers to find ways to get more doses faster. Early talks with Moderna and Pfizer led to increased commitments. "Those are some of the hardest negotiations I've done a lot of them," said one of the officials involved in the talks.
Then there was Johnson & Johnson. Its single-dose vaccine looked promising, but even before it had been approved for emergency use, it was clear that the company would not be able to meet its contracted production.
Then came the call, where White House officials got on the line with J&J executives to talk about the urgency of the situation.
"The basic conclusion of that call was, we've got to think much bigger and much bolder," recalled a senior administration official who was on the line. "We have to take bold action and overwhelm this."
That February call helped lead to an agreement with Merck a competitor that had given up on its own vaccine work to help produce J&J's vaccine and use its facilities to get it into vials.
The two companies had held some preliminary talks about working together before the Biden team got into the White House, but those proposals had been "at a very small level of ambition" and were "dead by the time we got in" to office, said the official, who knew the CEOs of both companies.
The official called J&J CEO Alex Gorsky to express concern and later called Merck CEO Kenneth Frazier. "I said, 'You know heads up there might be a need for Merck to help here,'" the official recalled.
But it was after the early February phone call that officials felt like J&J had embraced the push, said a second official who was involved in the talks. "They understood this was a wartime effort. This was their legacy. This was their time."
The Defense Production Act, which gives the government the power to compel companies to support war effort, provided some "implicit" incentive for the companies to cooperate, administration officials said. "You have the potential to use the DPA if there isn't cooperation," one of the officials said.
The resulting agreement came with an invocation of the DPA that helped accelerate some J&J vaccine deliveries to May that had earlier been set for June. It also will provide assistance to Merck. President Biden announced J&J would be running its U.S. facilities "24/7" to speed vaccine out the door.
Merck said it would receive up to $268.8 million in government funding to make adjustments to its facilities, where it will fill vials with J&J's vaccine and eventually also produce the drug substance used in the J&J vaccine. In a brief statement, Johnson & Johnson said it was "pleased to collaborate" with Merck on the arrangement to boost production.
The officials said getting Merck involved will vastly increase production of the Johnson & Johnson vaccine in the "medium term." That capacity may be needed to produce doses to vaccinate children, an official said, or to make a booster if variants diminish the efficacy of the current vaccine.
The Biden administration is racing against variants of COVID-19 that could make the existing vaccines less effective. Beyond simply getting the vaccines made and put into vials, they also have to get doses into arms, which is a massive undertaking involving everything from standing up mass vaccination clinics to recruiting retired medical professionals to administer shots. Soon the emphasis will turn from scarcity to persuasion as the administration and public health officials work to reach people who may be reluctant to get the vaccine.
Its just about being safe and as I was going through it, I had no idea what was going to happen, said Turner-Ford. You dont know if youre going to be one of the cases where you have to be hospitalized. You dont know if youre going to be one of the cases where youre going to need ICU treatment.
If you qualify for Medicaids transportation services, you can use this service to get a ride to your appointment to receive a COVID-19 vaccine.
Medicaid members who qualify can use this service to get transportation to receive a COVID-19 vaccine at any location offering vaccines.
You should use the contacts listed below to schedule your ride. Please try to schedule your ride 48 hours before your appointment.
If you receive medical and transportation services through one of the Healthy Louisiana health plans, use the contact below for your health plan to schedule your ride:
Aetna Better Health
1-877-917-4150
AmeriHealth Caritas
1-888-913-0364
Healthy Blue
1-866-430-1101
Louisiana Healthcare Connections
1-855-369-3723
United Healthcare Community Plan
1-866-726-1472
If you receive medical and transportation services through Legacy Medicaid, call Southeastrans to schedule your ride:
Southeastrans
1-855-325-7626
Click here to learn more about Non-Emergency Medical Transportation services.
Have questions about your coverage or if you qualify for Non-Emergency Medical Transportation services?
Call your health plan. Or call Medicaid Customer Service at 1-888-342-6207.
The Native Hawaiian and Pacific Islander community is disproportionally impacted by COVID-19 in Washington, according to the state Department of Health.
FEDERAL WAY, Wash. The Alamea is a thorny, spiny, tough starfish in Samoa.
We have a saying in Samoan tradition, and it is, E fofo le alamea le alamea, which translates as the spiny starfish heals itself, said Joseph Seia, executive director of the Pacific Islander Community Association of Washington.
Its a saying Seia lives by; it is even in the signature of his emails. He leans on the saying as he educates and advocates for his community.
We are experiencing a different pandemic than other communities, Seia told KING 5.
Native Hawaiian and Pacific Islanders are fighting a different battle against COVID-19 than most communities.
In our community, our elders are sacred treasures, and so, I think to lose that many elders in such a short time is pretty devastating, he explained.
According to the most recent data from the Washington State Department of Health, Native Hawaiian and Pacific Islanders have a four times higher case rate of COVID-19 than white populations.
Hospitalization rates are 10 times higher, and death rates from COVID-19 are nearly six times higher.
Theres an othering that happens there, said Seia. Like, your life is not worth it so you have to actually fight for a vaccine, right?
As more and more elders died from COVID-19, Seia called for the institutions in place to make a change. He reached out to healthcare providers and fought for his communitys life.
When we say its a life and death situation, it really is a life and death situation because we are racing against this, said Seia. If our people are dying at six times the rate, that literally means every week our elders are dying. Vaccine access is a critical issue for our community.
Seia told KING 5 the states COVID-19 vaccine rollout plan left out historically marginalized communities.
The way [the COVID-19 vaccine] rollout has occurred, it did not have any race analysis, said Seia. If King County public health is declaring that race is one of the biggest factors in determining the health of people, and that was not included in the rollout, accommodated for at all, you know, your rollout is, Im going to say it. Your rollout is racist."
Seias fight brought partnerships with health care providers like PeaceHealth, Swedish and more. They created popup vaccine clinics across the state from Federal Way to Spokane, cutting through language and technological barriers and brought the lifesaving vaccine to his community.
Because like the Alamea, that tough starfish, Seia knew he had the power to heal his community.
The spiny starfish heals itself, but its a belief that were the stewards of our own health, he said. Nobody else is going to heal us. We have the ability to heal ourselves.
While hundreds of elders have been vaccinated due to the Pacific Islander Community Associations work, that work is not done yet.
Seia said theyll keep going until that fight is over.
NEW YORK,3 March 2021Schools for more than 168 million children globally have been completely closed for almost an entire year due to COVID-19 lockdowns, according to new data released today by UNICEF. Furthermore, around 214 million children globally or 1 in 7 have missed more than three-quarters of their in-person learning.
The analysis on school closuresreport notes that 14 countries worldwide have remained largely closed since March 2020 to February 2021. Two-thirds of those countries are in Latin America and the Caribbean, affecting nearly 98 million schoolchildren. Of the 14 countries, Panama has kept schools closed for the most days, followed by El Salvador, Bangladesh, and Bolivia.
As we approach the one-year mark of the COVID-19 pandemic, we are again reminded of the catastrophic education emergency worldwide lockdowns have created. With every day that goes by, children unable to access in-person schooling fall further and further behind, with the most marginalized paying the heaviest price, said Henrietta Fore UNICEF Executive Director. We cannot afford to move into year two of limited or even no in-school learning for these children. No effort should be spared to keep schools open, or prioritise them in reopening plans.
Table 1: Number of countries/children where schools have remained closed since March 2020*
Schools have remained closed almostan entire year (# of countries)
School children affectedNumber (in millions)
School children affectedPer centage
East Asia & the Pacific
1
25
15%
Middle East & North Africa
3
9
5%
East & Southern Africa
0
n.a.
n.a.
Western & Central Africa
0
n.a.
n.a.
Europe & Central Asia
0
n.a.
n.a.
Latin America & the Caribbean
9
98
58%
South Asia
1
37
22%
TOTAL
14
168
100%
School closures have devastating consequences for childrens learning and wellbeing. The most vulnerable children and those unable to access remote learning are at an increased risk of never returning to the classroom, and even being forced into child marriage or child labor. According to latest data by UNESCO, more than 888 million children worldwide continue to face disruptions to their education due to full and partial school closures.
The majority of schoolchildren worldwide rely on their schools as a place where they can interact with their peers, seek support, access health and immunization services and a nutritious meal. The longer schools remain closed, the longer children are cut off from these critical elements of childhood.
To call attention to the education emergency and raise awareness about the need for governments to keep schools open, or prioritise them in reopening plans, UNICEF today unveiled Pandemic Classroom, a model classroom made up of 168 empty desks, each desk representing the million children living in countries where schools have been almost entirely closed a solemn reminder of the classrooms in every corner of the world that remain empty.
This classroom represents the millions of centers of learning that have sat emptymany for almost the entire year. Behind each empty chair hangs an empty backpacka placeholder for a childs deferred potential, said Fore. We do not want shuttered doors and closed buildings to obscure the fact that our childrens futures are being put on indefinite pause. This installation is a message to governments: we must prioritize reopening schools, and we must prioritize reopening them better than they were before.
As students return to their classrooms, they will need support to readjust and catch up on their learning. School reopening plans must incorporate efforts to recover childrens lost education. UNICEF urges governments to prioritise the unique needs of every student, with comprehensive services covering remedial learning, health and nutrition, and mental health and protection measures in schools to nurture children and adolescents development and wellbeing. UNICEFs Framework for Reopening Schools, issued jointly with UNESCO, UNHCR, WFP and the World Bank, offers practical advice for national and local authorities.
#####
Notes to Editors
*Countries were identified based on the number of instruction days since 11 March 2020, the reference date for when schools were fully closed, to February 2021. The data reflect school closure status over the past 11 months. In cases where countries had less than 10 days of fully opened schooling and less than 12 days of partially open schooling, they were deemed as remaining closed for almost a year of instruction time. The analysis covers from the pre-primary education to the upper secondary education.
Governor Andrew M. Cuomo today announced 121,067 first and second doses of the COVID-19 vaccine have been administered in the last 24 hours. As of 11:00 AM today, New York providers have administered 95 percent of first doses. The week 12 allocation from the federal government is in the process of being delivered to providers for administration.
"We remain locked in a footrace to keep the infection and hospitalization rate low and drive the vaccination rate up."Governor Cuomo said."We're making progress on both fronts, and thanks to our vast network of vaccine providers and targeted community efforts, over 15 percent of all New Yorkers have now been vaccinated with at least one dose. The light at the end of the tunnel is bright, and we will continue to get shots in arms quickly and fairly until every New Yorker is vaccinated and we are the first COVID-free state.
Approximately 10 million New Yorkers are currently eligible to receive the vaccine. New York's vast distribution network and large population of eligible individuals still far exceed the supply coming from the federal government. Due to limited supply, New Yorkers are encouraged to remain patient and are advised not to show up at vaccination sites without an appointment.
The'Am I Eligible'screening tool has been updated for individuals with comorbidities and underlying conditions with new appointments released on a rolling basis over the next weeks. New Yorkers can use the following to show they are eligible:
Vaccination program numbers below are for doses distributed and delivered to New York for the state's vaccination program, and do not include those reserved for the federal government's Long Term Care Facility program. A breakdown of the data based on numbers reported to New York State as of 11:00 AM today is as follows. Beginning week 9, allocation totals are inclusive of some excess vaccine doses that have been reallocated from the federal Long Term Care Facility program. The allocation totals below include 20 percent of the week 12 allocation which will finish being distributed to New York provider sites on Sunday.
STATEWIDE BREAKDOWN
First Doses Received - 3,290,980
First Doses Administered - 3,125,025; 95%
Total Doses Received - 5,372,605
TotalDoses Administered - 4,819,412
Region
Total Doses Received
(1st and 2nd)
Total Doses Administered
(1st and 2nd)
% of Total Doses Administered/Received
(1st and 2nd)
Capital Region
332,060
299,234
90.1%
Central New York
288,920
259,107
89.7%
Finger Lakes
329,705
300,941
91.3%
Long Island
691,660
591,280
85.5%
Mid-Hudson
520,305
433,776
83.4%
Mohawk Valley
161,615
134,416
83.2%
New York City
2,335,540
2,142,997
91.8%
North Country
178,450
162,516
91.1%
Southern Tier
178,890
166,799
93.2%
Western New York
355,460
328,346
92.4%
Statewide
5,372,605
4,819,412
89.7%
1st doses fully delivered to New York Providers
2nd doses fully delivered to New York Providers
TOTAL
CUMULATIVE
Week 1
Doses arriving 12/14 - 12/20
163,650
0
163,650
163,650
Week 2
Doses arriving 12/21 - 12/27
452,125
0
452,125
615,775
Week 3
Doses arriving 12/28 - 01/03
227,395
In a major shift in policy, California officials said Wednesday night they will now devote 40% of available COVID-19 vaccines to residents in the most disadvantaged areas in a move designed to both slow the spread of coronavirus and speed up the reopening of the economy.
After roughly another 400,000 doses are administered to people who live in Californias hardest hit communities which could happen within the next two weeks officials in Gov. Gavin Newsoms administration said the state intends to significantly relax the rules for counties to exit the most restrictive tier of Californias coronavirus reopening blueprint.
The shift comes amid mounting evidence that Latino and Black communities are falling behind white and Asian ones in getting access to the vaccine. This has sparked concern in part because those underserved communities have been hardest hit by COVID-19. They are home to many essential workers, who have contracted the virus on the job and then spread it at home.
But the move adds yet another shift in the states rocky vaccine rollout, which has been marked by big shortages of supply. It comes at a time when more people are becoming eligible for immunizations.
In a few weeks, the state will recommend to counties that millions of people with underlying health problems and disabilities join the line. With large amounts of vaccine now reserved, there will be less to go around to other groups. Officials are hoping for major boosts in vaccine supply in the coming weeks.
Newsom himself foreshadowed the concept during a briefing in Long Beach early Wednesday afternoon, though he did not offer specifics at that time.
We want to incorporate vaccination rates into the tiering, and that will allow people to move more quickly through the tiers, he said.
Currently, 1.6 million COVID-19 vaccine doses have been administered to individuals who live in the states hardest-hit communities specifically, those in the lowest quartile of the California Healthy Places index, a measure of socioeconomic opportunity that takes into account economic, social, education, housing and transportation factors.
Once 2 million doses have been administered in these communities, the state will relax the threshold by which a county can exit the most restrictive purple category of the states four-tier, color-coded reopening plan. In that category, indoor operations are forbidden or severely limited at many businesses and public spaces, including restaurant dining rooms, gyms, museums, zoos and aquariums.
In Southern California, targeted communities would include South Los Angeles, the Eastside, Koreatown, Chinatown, Compton, southeast L.A. County, the eastern San Fernando Valley, Santa Ana, and a number of heavily Latino communities along the Interstate 10 corridor between Pomona and San Bernardino.
Administration officials said that quartile consists of roughly 400 different ZIP codes sprinkled throughout the state, though many of them are in the Central Valley and in and around Los Angeles County.
Counties tier assignments are based on three criteria: average daily case rates, adjusted based on the number of tests performed; the testing positivity rate; and a health equity metric intended to ensure that the positivity rate in poorer communities is not significantly worse than the countys overall figure.
Currently, counties generally must have an adjusted daily coronavirus case rate at or below 7.0 new cases per day per 100,000 people to move from the purple tier to the more permissive red tier.
After the state achieves its 2-million dose goal, however, counties with a case rate of up to 10 new cases per day per 100,000 people will become eligible for the red tier.
The change in policy stands to accelerate the movement for many Southern California counties, allowing them to broadly reopen their economies sooner. Under the new proposed rules, L.A., Orange and San Bernardino counties would already be eligible to exit the purple tier, while Riverside, Ventura and San Diego counties would also be close to qualifying.
Per 100,000 residents, L.A. County currently has an adjusted daily case rate of 7.2; Orange, 7.6; Riverside, 11.3; San Bernardino, 9; San Diego, 10.8 and Ventura, 10.6.
Once a total of 4 million doses are administered to these lower-income communities, state officials will also relax the thresholds for entering the subsequent tiers, the orange and yellow tiers. However, they did not specify what those new thresholds would be.
The orange tier would allow sports fans to return to outdoor professional sports venues and allow indoor family entertainment centers like bowling alleys and escape rooms to reopen; the yellow tier allows large theme parks to reopen.
Even with these steps, we will still have some of the strongest public health protections in the nation, said one Newsom administration official.
Administration officials confirmed that the states previously announced dedicated dose share for educators 10% of Californias weekly allotment will remain in place.
Providers throughout California have administered more than 9.4 million total COVID-19 vaccine doses to date. Though the state has worked to ramp up how quickly available shots are going into arms, tens of millions of residents are still waiting for their turn in line.
Along with promoting equity in the states vaccine rollout, the administration officials said the plan discussed Wednesday is pragmatic. Vaccinating those most at risk of being victims or vectors of the coronavirus will help stymie its spread. Plus, vaccinating significant numbers of people better armors the wider community against widespread transmission meaning the thresholds to more widely reopen businesses and public spaces no longer will need to be as strict.
Though she said she wasnt privy to the specifics of the proposal, Los Angeles County Public Health Director Barbara Ferrer said Wednesday afternoon that she thinks it would make sense for vaccinations to play some kind of role in guiding the reopening process.
Once you are vaccinating millions and millions of people, you need to take that into account as you determine the safety of a variety of activities, she said during a briefing Wednesday. I think thats completely appropriate. I mean, we said that all along: vaccines are, in fact, a game changer. But you have to have lots and lots of people getting vaccinated before its going to make a big difference.
State officials are targeting COVID-19 vaccinations for people who live in the lowest quartile of the California Healthy Places index, places that are generally lower income, have crowded housing and have been hit hardest by the pandemic.
(California Healthy Places Index)
Lin reported from San Francisco; Money from Long Beach.
WINK NEWS
Thousands have already received the COVID-19 vaccine while others say not so fast.
Their big concern? Its impacts on possibly having children.
Fertility and pregnancy concerns are leading to vaccine hesitancy, and researchers are hoping to dispel the myths.
What if there is something in there that wasnt tested that will cause females to be sterile? asked Stacey Clarke, whos concerned about fertility issues with the vaccine.
It just leaves me feeling uneasy, said Nicole Linsley, a fertility patient.
Its not just women who have vaccine anxiety. Dr. Ranjith Ramasamy with the University of Miami said his male patients ask questions, too.
The concern with the potential of the vaccine, the COVID vaccine, causing male fertility issues arises from the fact that the actual COVID virus can bind to receptors inside the testes, said Ramasamy, the director of reproductive urology at the Miller School of Medicine.
In a previous study, Ramasamy found the coronavirus in mens testes, and for some men, it temporarily lowered their sperm counts. But Ramasamy says because both the Pfizer and Moderna vaccines dont use the actual virus, they likely wont impact male fertility.
People think that the vaccine actually has the virus in it. But the Pfizer and the Moderna vaccines that have emergency use authorization from the FDA, are just the mRNA vaccines that make a protein that the COVID virus expresses. So it is not the full virus and it does not biologically appear to actually bind to the testes and affect testicular function, he said.
The Johnson and Johnson vaccine could be a different story.
The J&J vaccine is the actual virus. And so now all of the concerns about the potential virus binding to the testes and impacting sperm count remains, and probably remains more with the J&J vaccine compared to the Pfizer and the Moderna vaccines, Ramasamy said.
Still, Ramasamy recommends if youre eligible to get the vaccine, you should get it.
National medical experts say the loss of fertility is scientifically unlikely. In a joint statement,the American College of Obstetricians and Gynecologists (ACOG), the American Society for Reproductive Medicine (ASRM), and the Society for Maternal-Fetal Medicine (SMFM) said:
Throughout the COVID-19 pandemic, patients have had questions about the impact of the virus on their health. Now, as the rollout of the COVID vaccines progresses, patients similarly have questions about whether the vaccine is right for their individual health needs.As experts in reproductive health, we continue to recommend that the vaccine be available to pregnant individuals. We also assure patients that there is no evidence that the vaccine can lead to loss of fertility. While fertility was not specifically studied in the clinical trials of the vaccine, no loss of fertility has been reported among trial participants or among the millions who have received the vaccines since their authorization, and no signs of infertility appeared in animal studies. Loss of fertility is scientifically unlikely.
Out of abundance of caution and to provide reassurance to the public, we are actually doing a study at the University of Miami to evaluate the effect of the vaccine on male fertility and male testosterone production. We believe that it shouldnt really affect male fertility or testosterone production, said Ramasamy. We see a lot of young men who are attempting conception right now or attempting fertility, who want to preserve their future fertility, and have actually told us that theyre willing to wait for the study results, to reassure them before they go ahead and get the vaccine.
So far, there is no data to suggest the vaccines negatively impact womens fertility. In fact, in studies done by Pfizer and Moderna, several women participating in clinical trials got pregnant.
`;// articleContent = document.querySelector(".article-content");// articleContent.innerHTML = articleContent.innerHTML + formbox;let firstParagraph = document.querySelector("div.article-content > p:nth-child(1)");if (firstParagraph !== null) {firstParagraph.insertAdjacentHTML("afterend", formbox);}function waitForElement(id, callback){var goStahp = setInterval(function(){if(document.getElementById(id)){clearInterval(goStahp);callback();}}, 100);}waitForElement("JotFormIFrame-202185815209151", function(){const expandButton = document.querySelector('h3.expand_box_click_to_open_covid_form');expandButton.addEventListener('click', function() {let box = document.querySelector('.corona_form_expand_box_covid_form');let first = 'opening';let second = 'open';let buttonAction = 'Hide story tip submission form';let deviceAction = "Tap";if (window.innerWidth > 666) {deviceAction = "Click";}// console.log(window.innerWidth);if(box.classList.contains(first)) {[first, second] = [second, first];buttonAction = `${deviceAction} to submit a coronavirus story tip`;}expandButton.innerHTML = buttonAction;box.classList.toggle(first);setTimeout(() => {box.classList.toggle(second);}, 0);});var ifr = document.getElementById("JotFormIFrame-202185815209151");if(window.location.href && window.location.href.indexOf("?") > -1) {var get = window.location.href.substr(window.location.href.indexOf("?") + 1);if(ifr && get.length > 0) {var src = ifr.src;src = src.indexOf("?") > -1 ? src + "&" + get : src + "?" + get;ifr.src = src;}}window.handleIFrameMessage = function(e) {if (typeof e.data === 'object') { return; }var args = e.data.split(":");if (args.length > 2) { iframe = document.getElementById("JotFormIFrame-" + args[(args.length - 1)]); } else { iframe = document.getElementById("JotFormIFrame"); }if (!iframe) { return; }switch (args[0]) {case "scrollIntoView":iframe.scrollIntoView();break;case "setHeight":console.log(`case: setHeight`);iframe.style.height = parseInt(args[1]) + 15 + "px";break;case "collapseErrorPage":console.log(`case: collapseErrorPage`);if (iframe.clientHeight > window.innerHeight) {iframe.style.height = window.innerHeight + "px";}break;case "reloadPage":window.location.reload();break;case "loadScript":var src = args[1];if (args.length > 3) {src = args[1] + ':' + args[2];}var script = document.createElement('script');script.src = src;script.type = 'text/javascript';document.body.appendChild(script);break;case "exitFullscreen":if (window.document.exitFullscreen) window.document.exitFullscreen();else if (window.document.mozCancelFullScreen) window.document.mozCancelFullScreen();else if (window.document.mozCancelFullscreen) window.document.mozCancelFullScreen();else if (window.document.webkitExitFullscreen) window.document.webkitExitFullscreen();else if (window.document.msExitFullscreen) window.document.msExitFullscreen();break;}var isJotForm = (e.origin.indexOf("jotform") > -1) ? true : false;if(isJotForm && "contentWindow" in iframe && "postMessage" in iframe.contentWindow) {var urls = {"docurl":encodeURIComponent(document.URL),"referrer":encodeURIComponent(document.referrer)};iframe.contentWindow.postMessage(JSON.stringify({"type":"urls","value":urls}), "*");}};if (window.addEventListener) {window.addEventListener("message", handleIFrameMessage, false);} else if (window.attachEvent) {window.attachEvent("onmessage", handleIFrameMessage);}});//
